siltuximab (Sylvant)

From Aaushi
Jump to navigation Jump to search

Indications

Contraindications

Mechanism of action

More general terms

References

  1. American Cancer Society. April 29, 2014 FDA Approves Sylvant (Siltuximab) for Castleman Disease http://www.cancer.org/cancer/news/fda-approves-sylvant-siltuximab-for-castleman-disease
  2. Wikipedia: Siltuximab http://en.wikipedia.org/wiki/Siltuximab
  3. Chustecka Z Medscape: April 24, 2014 Siltuximab: First-Ever Drug for Castleman's Disease http://www.medscape.com/viewarticle/824072